Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 215

1.

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial.

French N, Nakiyingi J, Carpenter LM, Lugada E, Watera C, Moi K, Moore M, Antvelink D, Mulder D, Janoff EN, Whitworth J, Gilks CF.

Lancet. 2000 Jun 17;355(9221):2106-11.

PMID:
10902624
[PubMed - indexed for MEDLINE]
2.

Pneumococcal vaccination in HIV-1-infected adults in Uganda: humoral response and two vaccine failures.

French N, Gilks CF, Mujugira A, Fasching C, O'Brien J, Janoff EN.

AIDS. 1998 Sep 10;12(13):1683-9.

PMID:
9764789
[PubMed - indexed for MEDLINE]
3.

Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients.

Breiman RF, Keller DW, Phelan MA, Sniadack DH, Stephens DS, Rimland D, Farley MM, Schuchat A, Reingold AL.

Arch Intern Med. 2000 Sep 25;160(17):2633-8.

PMID:
10999977
[PubMed - indexed for MEDLINE]
4.

23-Valent pneumococcal polysaccharide vaccine in HIV-infected Ugandan adults: 6-year follow-up of a clinical trial cohort.

Watera C, Nakiyingi J, Miiro G, Muwonge R, Whitworth JA, Gilks CF, French N.

AIDS. 2004 May 21;18(8):1210-3.

PMID:
15166540
[PubMed - indexed for MEDLINE]
5.

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.

Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N; Vaccine Trialists Group.

N Engl J Med. 2003 Oct 2;349(14):1341-8.

PMID:
14523142
[PubMed - indexed for MEDLINE]
Free Article
6.

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults.

French N, Gordon SB, Mwalukomo T, White SA, Mwafulirwa G, Longwe H, Mwaiponya M, Zijlstra EE, Molyneux ME, Gilks CF.

N Engl J Med. 2010 Mar 4;362(9):812-22. doi: 10.1056/NEJMoa0903029.

PMID:
20200385
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.

Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, Oluwalana C, Vaughan A, Obaro SK, Leach A, McAdam KP, Biney E, Saaka M, Onwuchekwa U, Yallop F, Pierce NF, Greenwood BM, Adegbola RA; Gambian Pneumococcal Vaccine Trial Group.

Lancet. 2005 Mar 26-Apr 1;365(9465):1139-46. Erratum in: Lancet. 2005 Jul 2-8;366(9479):28.

PMID:
15794968
[PubMed - indexed for MEDLINE]
8.

Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study.

Hung CC, Chen MY, Hsieh SM, Hsiao CF, Sheng WH, Chang SC.

Vaccine. 2004 May 7;22(15-16):2006-12.

PMID:
15121313
[PubMed - indexed for MEDLINE]
9.

Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine.

Miiro G, Kayhty H, Watera C, Tolmie H, Whitworth JA, Gilks CF, French N.

J Infect Dis. 2005 Nov 15;192(10):1801-5. Epub 2005 Oct 5.

PMID:
16235180
[PubMed - indexed for MEDLINE]
Free Article
10.

Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial.

Ahmed F, Steinhoff MC, Rodriguez-Barradas MC, Hamilton RG, Musher DM, Nelson KE.

J Infect Dis. 1996 Jan;173(1):83-90.

PMID:
8537687
[PubMed - indexed for MEDLINE]
Free Article
11.

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group.

Ortqvist A, Hedlund J, Burman LA, Elbel E, Höfer M, Leinonen M, Lindblad I, Sundelöf B, Kalin M.

Lancet. 1998 Feb 7;351(9100):399-403.

PMID:
9482293
[PubMed - indexed for MEDLINE]
13.

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection.

Nachman S, Kim S, King J, Abrams EJ, Margolis D, Petru A, Shearer W, Smith E, Moye J, Blanchard S, Hawkins E, Bouquin P, Vink P, Benson M, Estep S, Malinoski F; Pediatric AIDS Clinical Trials Group Study 292 Team.

Pediatrics. 2003 Jul;112(1 Pt 1):66-73.

PMID:
12837869
[PubMed - indexed for MEDLINE]
14.

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group.

Anglaret X, Chêne G, Attia A, Toure S, Lafont S, Combe P, Manlan K, N'Dri-Yoman T, Salamon R.

Lancet. 1999 May 1;353(9163):1463-8.

PMID:
10232311
[PubMed - indexed for MEDLINE]
15.

Streptococcus pneumoniae colonization among patients with human immunodeficiency virus-1 who had received 23-valent polysaccharide pneumococcal vaccine.

Lo YC, Lauderdale TL, Chang SY, Hsiao CF, Hung CC, Chang SC.

J Microbiol Immunol Infect. 2009 Jun;42(3):234-42.

PMID:
19812857
[PubMed - indexed for MEDLINE]
16.

Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults.

Lesprit P, Pédrono G, Molina JM, Goujard C, Girard PM, Sarrazin N, Katlama C, Yéni P, Morineau P, Delfraissy JF, Chêne G, Lévy Y; ANRS 114-Pneumovac Study Group.

AIDS. 2007 Nov 30;21(18):2425-34.

PMID:
18025879
[PubMed - indexed for MEDLINE]
17.

Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial.

Lucero MG, Nohynek H, Williams G, Tallo V, Simões EA, Lupisan S, Sanvictores D, Forsyth S, Puumalainen T, Ugpo J, Lechago M, de Campo M, Abucejo-Ladesma E, Sombrero L, Nissinen A, Soininen A, Ruutu P, Riley I, Mäkelä HP.

Pediatr Infect Dis J. 2009 Jun;28(6):455-62. doi: 10.1097/INF.0b013e31819637af.

PMID:
19483514
[PubMed - indexed for MEDLINE]
18.

A case-control study to investigate serological correlates of clinical failure of 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults.

French N, Moore M, Haikala R, Kayhty H, Gilks CF.

J Infect Dis. 2004 Aug 15;190(4):707-12. Epub 2004 Jul 16.

PMID:
15272398
[PubMed - indexed for MEDLINE]
Free Article
19.

Improving the immunogenicity of pneumococcal conjugate vaccine in HIV-infected adults with a toll-like receptor 9 agonist adjuvant: a randomized, controlled trial.

Søgaard OS, Lohse N, Harboe ZB, Offersen R, Bukh AR, Davis HL, Schønheyder HC, Østergaard L.

Clin Infect Dis. 2010 Jul 1;51(1):42-50. doi: 10.1086/653112.

PMID:
20504165
[PubMed - indexed for MEDLINE]
Free Article
20.

Viral load response to a pneumococcal conjugate vaccine, polysaccharide vaccine or placebo among HIV-infected patients.

Goetz MB, Feikin DR, Lennox JL, O'Brien WA, Elie CM, Butler JC, Breiman RF.

AIDS. 2002 Jul 5;16(10):1421-3.

PMID:
12131220
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk